Pharmathen

Pharmathen is a prominent player in the biotechnology, healthcare, and pharmaceutical industries. Established in 1969, the company has evolved into a leading vertically integrated developer of complex drug delivery technologies. With a strong dedication to improving lives through innovation and access to affordable medicines, Pharmathen boasts an extensive and advanced pipeline. Their focus on long-acting injectables, sustained release, and ophthalmic formulations is backed by a diversified portfolio of over 90 commercialized products, manufactured in US FDA and EU-approved facilities in Greece. The company's commitment to innovation is evident in its development of three fully certified technological platforms to expand its offerings with Long-Acting Therapeutic Technologies (LATTs). This strategic move not only broadens their therapy range but also supports product Life Cycle Management (LCM) opportunities for customers, ensuring sustainability and growth. Furthermore, Pharmathen has established a strong global presence, collaborating with significant organizations in the pharmaceutical market across more than 90 countries. Pharmathen takes pride in its diverse workforce, employing over 1,600 individuals from 28 different nationalities, with a notable focus on gender diversity, with 54% of its total workforce and 66% of its Research Operations Team being female. This emphasis on diversity aligns with the company's core values of creativity, strong ethics, and dedication, contributing to its enduring success. Overall, Pharmathen stands out as a forward-thinking and influential player in the pharmaceutical industry, consistently driving innovation and making a meaningful impact on global healthcare.